首頁 › 乳癌 › 堪薩斯 › Overland Park
Overland Park, KS 的 乳癌 臨床試驗
10 項針對 乳癌 的研究正在 Overland Park(約 30 英里範圍內)及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本(英文)
正在為研究招募對象嗎?將此頁面置頂展示 — $99 / 30 天 →
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
招募中1/2 期
- University of Kansas Hospital-Cancer Center, Fairway · 距離 3 英里
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
招募中3 期
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
招募中觀察性研究歡迎健康志工
- KCCC Overland Park, Overland Park
- Overland Park Regional Medical Center, Overland Park
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
招募中3 期
- University of Kansas Cancer Center-Overland Park, Overland Park
Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC
招募中2 期
- University of Kansas Medical Center, Fairway · 距離 3 英里
Integrated Cancer Repository for Cancer Research
招募中觀察性研究歡迎健康志工
- Saint Luke's Cancer Instititute - South, Overland Park
Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer
招募中2 期
- KUCC - Indian Creek, Overland Park
- KUCC - Overland Park, Overland Park
- The University of Kansas Cancer Center (KUCC), Fairway · 距離 3 英里
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
招募中3 期
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
招募中觀察性研究
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
招募中3 期
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
其他城市的 乳癌 試驗
- New York City, NY136 項研究
- Houston, TX126 項研究
- Boston, MA112 項研究
- Nashville, TN81 項研究
- Los Angeles, CA73 項研究
- Edison, NJ68 項研究
- St. Louis, MO64 項研究
- Queens, NY64 項研究
- Durham, NC64 項研究
- Chicago, IL59 項研究
- Philadelphia, PA56 項研究
- Dallas, TX55 項研究
Overland Park 的其他研究
- 非小細胞肺癌16 項研究
- 急性髓系白血病11 項研究
- 肺癌11 項研究
- 心房顫動8 項研究
- 大腸直腸癌8 項研究
- 肥胖症7 項研究
- 胰臟癌7 項研究
- 前列腺癌7 項研究
- 黑色素瘤6 項研究
- 過重6 項研究
- 卵巢癌6 項研究
- 癌症(所有類型)5 項研究
資料來源:ClinicalTrials.gov,擷取日期 2026年10月6日。各研究自行設定資格標準;由研究團隊決定參與者資格。